Loading provider…
Loading provider…
Medical Oncology Physician in Detroit, MI
NPI: 1174816045Primary Practice Location
KARMANOS CANCER CENTER
4100 John R St, Detroit, MI
Primary Employer
Wayne Health
waynehealthcares.org
HQ Phone
Get MD Frank's Phone NumberMobile
Get MD Frank's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 62 | 156 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 35 | 61 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 18 | 18 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 11 |
Breast Cancer Disseminated Tumor Cells: Do They Stay and Fight or Run and Hide?
Authors: Cackowski, Frank C, Korkaya, Hasan
Journal: Cancer Res
Authors: Wang, Yu, Herroon, Mackenzie K, Zielske, Steven P, Ellis, Leigh, Podgorski, Izabela, Taichman, Russell S, Cackowski, Frank C
Journal: J Bone Oncol
Publication Date: 2021-08-18
CXCL12γ induces human prostate and mammary gland development.
Authors: Younghun Jung, Jin Kim, Eunsohl Lee, Frank Cackowski, Ann Decker, Paul Krebsbach, Russell Taichman
Publication Date: 2020-02-27
Lead Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, BIOLOGICAL: HER2Bi-Armed Activated T Cells